coin-img-ETHETH+0.70%coin-img-FOGOFOGO-7.77%coin-img-SPORTFUNSPORTFUN-13.16%coin-img-XUEQIUXUEQIU+5.45%coin-img-BTCBTC-0.11%coin-img-SOLSOL-1.49%coin-img-XRPXRP-0.49%coin-img-USDCUSDC-0.01%coin-img-ETHETH+0.70%coin-img-FOGOFOGO-7.77%coin-img-SPORTFUNSPORTFUN-13.16%coin-img-XUEQIUXUEQIU+5.45%coin-img-BTCBTC-0.11%coin-img-SOLSOL-1.49%coin-img-XRPXRP-0.49%coin-img-USDCUSDC-0.01%coin-img-ETHETH+0.70%coin-img-FOGOFOGO-7.77%coin-img-SPORTFUNSPORTFUN-13.16%coin-img-XUEQIUXUEQIU+5.45%coin-img-BTCBTC-0.11%coin-img-SOLSOL-1.49%coin-img-XRPXRP-0.49%coin-img-USDCUSDC-0.01%coin-img-ETHETH+0.70%coin-img-FOGOFOGO-7.77%coin-img-SPORTFUNSPORTFUN-13.16%coin-img-XUEQIUXUEQIU+5.45%coin-img-BTCBTC-0.11%coin-img-SOLSOL-1.49%coin-img-XRPXRP-0.49%coin-img-USDCUSDC-0.01%
user-avatar
Tim Fries

Boston Scientific to Acquire Penumbra for $14.5 Billion as BSX Falls 3.6% on January 15, 2026

Boston Scientific said on Thursday, January 15, 2026, that it will acquire Penumbra in a cash-and-stock deal valuing the target at about $14.5 billion, or $374 per share, a roughly 19% premium. Following the announcement, Boston Scientific's stock slid 3.61% in premarket trading to $90.35, while Penumbra shares jumped in early action.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks